- Home
- LDWY vs DOMH Comparison
LDWY vs DOMH Comparison
Compare LDWY & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDWY
- DOMH
- Stock Information
- Founded
- LDWY 1990
- DOMH 1967
- Country
- LDWY United States
- DOMH United States
- Employees
- LDWY N/A
- DOMH N/A
- Industry
- LDWY Advertising
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- LDWY Consumer Discretionary
- DOMH Health Care
- Exchange
- LDWY Nasdaq
- DOMH Nasdaq
- Market Cap
- LDWY 8.2M
- DOMH 8.8M
- IPO Year
- LDWY 1991
- DOMH N/A
- Fundamental
- Price
- LDWY $4.25
- DOMH $4.59
- Analyst Decision
- LDWY
- DOMH
- Analyst Count
- LDWY 0
- DOMH 0
- Target Price
- LDWY N/A
- DOMH N/A
- AVG Volume (30 Days)
- LDWY 4.4K
- DOMH 427.5K
- Earning Date
- LDWY 03-31-2025
- DOMH 03-31-2025
- Dividend Yield
- LDWY N/A
- DOMH N/A
- EPS Growth
- LDWY N/A
- DOMH N/A
- EPS
- LDWY N/A
- DOMH N/A
- Revenue
- LDWY $31,581,000.00
- DOMH $12,589,000.00
- Revenue This Year
- LDWY N/A
- DOMH N/A
- Revenue Next Year
- LDWY N/A
- DOMH N/A
- P/E Ratio
- LDWY N/A
- DOMH N/A
- Revenue Growth
- LDWY N/A
- DOMH 1117.50
- 52 Week Low
- LDWY $3.02
- DOMH $0.83
- 52 Week High
- LDWY $6.88
- DOMH $5.92
- Technical
- Relative Strength Index (RSI)
- LDWY 47.81
- DOMH 79.30
- Support Level
- LDWY $4.13
- DOMH $2.55
- Resistance Level
- LDWY $4.55
- DOMH $4.35
- Average True Range (ATR)
- LDWY 0.22
- DOMH 0.62
- MACD
- LDWY -0.02
- DOMH 0.17
- Stochastic Oscillator
- LDWY 39.98
- DOMH 82.13
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two Industry Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.